Biomarkers in acute myocardial infarction
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Myocardial infarction causes significant mortality and morbidity. Timely diagnosis allows clinicians to risk stratify their patients and select appropriate treatment. Biomarkers have been used to assist with timely diagnosis, while an increasing number of novel markers have been identified to predict outcome following an acute myocardial infarction or acute coronary syndrome. This may facilitate tailoring of appropriate therapy to high-risk patients. This review focuses on a variety of promising biomarkers which provide diagnostic and prognostic information. Heart-type Fatty Acid Binding Protein and copeptin in combination with cardiac troponin help diagnose myocardial infarction or acute coronary syndrome in the early hours following symptoms. An elevated N-Terminal Pro-B-type Natriuretic Peptide has been well validated to predict death and heart failure following a myocardial infarction. Similarly other biomarkers such as Mid-regional pro-Atrial Natriuretic Peptide, ST2, C-Terminal pro-endothelin 1, Mid-regional pro-Adrenomedullin and copeptin all provide incremental information in predicting death and heart failure. Growth differentiation factor-15 and high-sensitivity C-reactive protein predict death following an acute coronary syndrome. Pregnancy associated plasma protein A levels following chest pain predicts risk of myocardial infarction and revascularisation. Some biomarkers such as myeloperoxidase and high-sensitivity C-reactive protein in an apparently healthy population predicts risk of coronary disease and allows clinicians to initiate early preventative treatment. In addition to biomarkers, various well-validated scoring systems based on clinical characteristics are available to help clinicians predict mortality risk, such as the Thrombolysis In Myocardial Infarction score and Global Registry of Acute Coronary Events score. A multimarker approach incorporating biomarkers and clinical scores will increase the prognostic accuracy. However, it is important to note that only troponin has been used to direct therapeutic intervention and none of the new prognostic biomarkers have been tested and proven to alter outcome of therapeutic intervention. Novel biomarkers have improved prediction of outcome in acute myocardial infarction, but none have been demonstrated to alter the outcome of a particular therapy or management strategy. Randomised trials are urgently needed to address this translational gap before the use of novel biomarkers becomes common practice to facilitate tailored treatment following an acute coronary event.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Antman, E., Bassand, J.-P., Klein, W., Ohman, M., Lopez Sendon, J. L., Rydén, L., Simoons, M., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,821
Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Clinical Investigation Group: Paul W. Armstrong, C. (., Global Perspective Group: Philip A. Poole-Wilson, C. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,230
Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., & Masaki, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2863 · Cited by 2,517
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513 · cited 1×
“An elevated C-reactive protein measured in seemingly healthy adults was associated with increased cardiovascular risk [81,82].”
BackgroundPredictors of Hospital Mortality in the Global Registry of Acute Coronary Events
Granger, C. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.19.2345 · Cited by 2,356
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292 · cited 1×
“Newer, higher sensitivity assays of CRP that detect lower levels of CRP (<5 mg/L) risk stratify patients into low, intermediate and high risk, with intermediate and high risk individuals benefiting from aggressive therapy [88].”
BackgroundSpontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237 · cited 1×
“It is thought that ST2/IL33 interaction also reduces atheroma burden [53].”
BackgroundAdrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma
Kitamura, K., Kangawa, K., Kawamoto, M., Ichiki, Y., Nakamura, S., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1451 · Cited by 2,192
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Epstein, F. H., Levin, E. R., Gardner, D. G., & Samson, W. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390507 · Cited by 1,927
Antman, E. M., Tanasijevic, M. J., Thompson, B., Schactman, M., McCabe, C. H., Cannon, C. P., Fischer, G. A., Fung, A. Y., Thompson, C., Wybenga, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351802 · Cited by 1,749
Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death
Davies, M. J., & Thomas, A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405033101801 · Cited by 1,694 · cited 1×
“Myeloperoxidase (MPO) Leucocytes play a central role in atherosclerotic plaque rupture [92-96].”
BackgroundUniversal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., & White, H. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.011 · Cited by 1,618
The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
de Lemos, J. A., Morrow, D. A., Bentley, J. H., Omland, T., Sabatine, M. S., McCabe, C. H., Hall, C., Cannon, C. P., & Braunwald, E. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011053 · Cited by 1,284
Alpert, J. S., Thygesen, K. A., Antman, E. M., & Bassand, J. (2001) · Journal of the American College of Cardiology · Cited by 1,282
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction
Keller, T., Zeller, T., Peetz, D., Tzikas, S., Roth, A., Czyz, E., Bickel, C., Baldus, S., Warnholtz, A., Fröhlich, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903515 · Cited by 1,150
Verma, S., Wang, C.-H., Li, S.-H., Dumont, A. S., Fedak, P. W. M., Badiwala, M. V., Dhillon, B., Weisel, R. D., Li, R.-K., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,054
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Münzel, T., Simoons, M. L., & Hamm, C. W. (2003) · Circulation · doi:10.1161/01.cir.0000090690.67322.51 · Cited by 1,013
Boersma, E., Pieper, K. S., Steyerberg, E. W., Wilcox, R. G., Chang, W.-C., Lee, K. L., Akkerhuis, K. M., Harrington, R. A., Deckers, J. W., Armstrong, P. W., et al. (2000) · Circulation · doi:10.1161/01.cir.101.22.2557 · Cited by 963
Widespread Coronary Inflammation in Unstable Angina
Buffon, A., Biasucci, L. M., Liuzzo, G., D'Onofrio, G., Crea, F., & Maseri, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012295 · Cited by 922
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., & Braunwald, E. (2002) · Circulation · doi:10.1161/01.cir.0000015464.18023.0a · Cited by 735
Omland, T., Aakvaag, A., Bonarjee, V. V. S., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J. A., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 700
Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes
Naruko, T., Ueda, M., Haze, K., van der Wal, A. C., van der Loos, C. M., Itoh, A., Komatsu, R., Ikura, Y., Ogami, M., Shimada, Y., et al. (2002) · Circulation · doi:10.1161/01.cir.0000042674.89762.20 · Cited by 660
Gheorghiade, M. (2004) · JAMA · doi:10.1001/jama.291.16.1963 · Cited by 651
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Richards, A. M., Nicholls, M. G., Yandle, T. G., Frampton, C., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Weinberg, E. O., Shimpo, M., De Keulenaer, G. W., MacGillivray, C., Tominaga, S.-I., Solomon, S. D., Rouleau, J.-L., & Lee, R. T. (2002) · Circulation · doi:10.1161/01.cir.0000038705.69871.d9 · Cited by 645
N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes
Omland, T., Persson, A., Ng, L., O’Brien, R., Karlsson, T., Herlitz, J., Hartford, M., & Caidahl, K. (2002) · Circulation · doi:10.1161/01.cir.0000041661.63285.ae · Cited by 576
Self-citationEndothelial Cells Actively Synthesize and Secrete Adrenomedullin
Sugo, S., Minamino, N., Kangawa, K., Miyamoto, K., Kitamura, K., Sakata, J., Eto, T., & Matsuo, H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1827 · Cited by 574
Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes
Bayes-Genis, A., Conover, C. A., Overgaard, M. T., Bailey, K. R., Christiansen, M., Holmes, D. R., Virmani, R., Oxvig, C., & Schwartz, R. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003147 · Cited by 561
de Araújo Gonçalves, P., Ferreira, J., Aguiar, C., & Seabra-Gomes, R. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi187 · Cited by 524
Tunstall-Pedoe, H., Vanuzzo, D., Hobbs, M., Mähönen, M., Cepaitis, Z., Kuulasmaa, K., & Keil, U. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11181-4 · Cited by 514
Meuwese, M. C., Stroes, E. S. G., Hazen, S. L., van Miert, J. N., Kuivenhoven, J. A., Schaub, R. G., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K.-T., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.033 · Cited by 441
Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
Reichlin, T., Hochholzer, W., Stelzig, C., Laule, K., Freidank, H., Morgenthaler, N. G., Bergmann, A., Potocki, M., Noveanu, M., Breidthardt, T., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.076 · Cited by 434 · cited 1×
“Copeptin can rule out MI earlier in addition to a negative Troponin T test [14].”
BackgroundMorrow, D. A., de Lemos, J. A., Sabatine, M. S., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Gibson, C. M., Cannon, C. P., & Braunwald, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00168-2 · Cited by 419
The Insulin-Like Growth Factor Axis: A Review of Atherosclerosis and Restenosis
Bayes-Genis, A., Conover, C. A., & Schwartz, R. S. (2000) · Circulation Research · doi:10.1161/01.res.86.2.125 · Cited by 416
Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., & Lee, R. T. (2004) · Circulation · doi:10.1161/01.cir.0000127958.21003.5a · Cited by 411
Wollert, K. C., Kempf, T., Peter, T., Olofsson, S., James, S., Johnston, N., Lindahl, B., Horn-Wichmann, R., Brabant, G., Simoons, M. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.650846 · Cited by 379
Seki, K., Sanada, S., Kudinova, A. Y., Steinhauser, M. L., Handa, V., Gannon;, J., & Lee, R. T. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.873240 · Cited by 365
T-cell-mediated lysis of endothelial cells in acute coronary syndromes
Nakajima, T., Schulte, S., Warrington, K. J., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2002) · Circulation · doi:10.1161/hc0502.103348 · Cited by 356
Khan, S. Q., Dhillon, O. S., O’Brien, R. J., Struck, J., Quinn, P. A., Morgenthaler, N. G., Squire, I. B., Davies, J. E., Bergmann, A., & Ng, L. L. (2007) · Circulation · doi:10.1161/circulationaha.106.685503 · Cited by 353
Self-citationElevation of Circulating and Ventricular Adrenomedullin in Human Congestive Heart Failure
Jougasaki, M., Wei, C.-M., McKinley, L. J., & Burnett, J. C. (1995) · Circulation · doi:10.1161/01.cir.92.3.286 · Cited by 352
Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction
Mocatta, T. J., Pilbrow, A. P., Cameron, V. A., Senthilmohan, R., Frampton, C. M., Richards, A. M., & Winterbourn, C. C. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.040 · Cited by 344
Anzai, T., Yoshikawa, T., Shiraki, H., Asakura, Y., Akaishi, M., Mitamura, H., & Ogawa, S. (1997) · Circulation · doi:10.1161/01.cir.96.3.778 · Cited by 335
Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human Plasma
Morgenthaler, N. G., Struck, J., Thomas, B., & Bergmann, A. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021204 · Cited by 335
Sabatine, M. S., Morrow, D. A., Higgins, L. J., MacGillivray, C., Guo, W., Bode, C., Rifai, N., Cannon, C. P., Gerszten, R. E., & Lee, R. T. (2008) · Circulation · doi:10.1161/circulationaha.107.728022 · Cited by 314
Elevated Soluble ST2 Protein Levels in Sera of Patients with Asthma with an Acute Exacerbation
OSHIKAWA, K., KUROIWA, K., TAGO, K., IWAHANA, H., YANAGISAWA, K., OHNO, S., TOMINAGA, S.-I., & SUGIYAMA, Y. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2008120 · Cited by 314
Increased plasma endothelin-1 in the early hours of acute myocardial infarction
Stewart, D. J., Kubac, G., Costello, K. B., & Cernacek, P. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80214-1 · Cited by 295
Haynes, W. G., Strachan, F. E., & Webb, D. J. (1995) · Circulation · doi:10.1161/01.cir.92.3.357 · Cited by 279
Copeptin and Arginine Vasopressin Concentrations in Critically Ill Patients
Jochberger, S., Morgenthaler, N. G., Mayr, V. D., Luckner, G., Wenzel, V., Ulmer, H., Schwarz, S., Hasibeder, W. R., Friesenecker, B. E., & Dünser, M. W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2830 · Cited by 271
Suleiman, M., Khatib, R., Agmon, Y., Mahamid, R., Boulos, M., Kapeliovich, M., Levy, Y., Beyar, R., Markiewicz, W., Hammerman, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.055 · Cited by 264 · cited 1×
“02) post-MI [89].”
Lund, J., Qin, Q.-P., Ilva, T., Pettersson, K., Voipio-Pulkki, L.-M., Porela, P., & Pulkki, K. (2003) · Circulation · doi:10.1161/01.cir.0000096054.18485.07 · Cited by 233
Berger, R., Moertl, D., Peter, S., Ahmadi, R., Huelsmann, M., Yamuti, S., Wagner, B., & Pacher, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.078 · Cited by 232
Wollert, K. C., Kempf, T., Lagerqvist, B., Lindahl, B., Olofsson, S., Allhoff, T., Peter, T., Siegbahn, A., Venge, P., Drexler, H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.697714 · Cited by 232
Kempf, T., Bjorklund, E., Olofsson, S., Lindahl, B., Allhoff, T., Peter, T., Tongers, J., Wollert, K. C., & Wallentin, L. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm465 · Cited by 227
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
Khan, S. Q., Ng, K., Dhillon, O., Kelly, D., Quinn, P., Squire, I. B., Davies, J. E., & Ng, L. L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn600 · Cited by 218
Self-citationO’Donoghue, M., de Lemos, J. A., Morrow, D. A., Murphy, S. A., Buros, J. L., Cannon, C. P., & Sabatine, M. S. (2006) · Circulation · doi:10.1161/circulationaha.106.641936 · Cited by 196
Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction
Arakawa, N., Nakamura, M., Aoki, H., & Hiramori, K. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00067-8 · Cited by 194
Nakamura, M., Yoshida, H., Makita, S., Arakawa, N., Niinuma, H., & Hiramori, K. (1997) · Circulation · doi:10.1161/01.cir.95.5.1214 · Cited by 184
Kelly, D., Cockerill, G., Ng, L. L., Thompson, M., Khan, S., Samani, N. J., & Squire, I. B. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm003 · Cited by 177
Self-citationNakagomi, A., Freedman, S. B., & Geczy, C. L. (2000) · Circulation · doi:10.1161/01.cir.101.15.1785 · Cited by 175
Plasma adrenomedullin concentration in patients with heart failure
Kato, J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.180 · Cited by 170
Itoi, K., Jiang, Y. ‐., Iwasaki, Y., & . Watson, S. J. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.0953-8194.2004.01172.x · Cited by 169
Prognostic Value of Midregional Pro-Adrenomedullin in Patients With Acute Myocardial Infarction
Khan, S. Q., O’Brien, R. J., Struck, J., Quinn, P., Morgenthaler, N., Squire, I., Davies, J., Bergmann, A., & Ng, L. L. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.038 · Cited by 168
Self-citationBiasucci, L. M., D'Onofrio, G., Liuzzo, G., Zini, G., Monaco, C., Caligiuri, G., Tommasi, M., Rebuzzi, A. G., & Maseri, A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00524-2 · Cited by 168
Ala-Kopsala, M., Magga, J., Peuhkurinen, K., Leipälä, J., Ruskoaho, H., Leppäluoto, J., & Vuolteenaho, O. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032490 · Cited by 162
Gheorghiade, M., Gattis, W. A., Connor, C. M., Adams, K. F., Kayam, U. E., Barbagelata, A., Ghali, J. K., Benza, R. L., McGrew, F. A., Klapholz, M., et al. (2004) · Cited by 153
Kelly, D., Khan, S., THOMPSON, M. M., COCKERILL, G. W., Ng, L. L., Samani, N. J., & Squire, I. B. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn315 · Cited by 152
Self-citationIdentification of Human ST2 Protein in the Sera of Patients with Autoimmune Diseases
Kuroiwa, K., Arai, T., Okazaki, H., Minota, S., & Tominaga, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5090 · Cited by 144
Kelly, D., Squire, I. B., Khan, S. Q., Quinn, P. A., Struck, J., Morgenthaler, N. G., Davies, J. E., & Ng, L. L. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.07.231 · Cited by 141
Self-citationTargeted Disruption of Smad4 in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure
Wang, J., Xu, N., Feng, X., Hou, N., Zhang, J., Cheng, X., Chen, Y., Zhang, Y., & Yang, X. (2005) · Circulation Research · doi:10.1161/01.res.0000185833.42544.06 · Cited by 140
Kilcullen, N. M., Viswanathan, K., Das, R., Morrell, C., Farrin, A. J., Barth, J. H., & Hall, A. S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.021 · Cited by 132
Luckenbill, K., Christenson, R. H., Jaffe, A. S., Mair, J., Ordóñez‐Llanos, J., Pagani, F., Tate, J. R., Wu, A. H. B., Ler, R., & Apple, F. S. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097998 · Cited by 132
Abraham, W. T., Shamshirsaz, A. A., McFann, K., Oren, R. M., & Schrier, R. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.071 · Cited by 130
Adrenomedullin: A Hypotensive Hormone in Man
Lainchbury, J. G., Cooper, G. J. S., Coy, D. H., Jiang, N., Lewis, L. K., Yandle, T. G., Richards, M., & Nicholls, M. G. (1997) · Clinical Science · doi:10.1042/cs0920467 · Cited by 105
Kelly, D., Khan, S., COCKERILL, G. W., Ng, L. L., THOMPSON, M. M., Samani, N. J., & Squire, I. B. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.12.009 · Cited by 104
Self-citationGoldsmith, S. R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90228-2 · Cited by 100
Direct cardiac and vascular actions of adrenomedullin in conscious sheep
Parkes, D. G., & May, C. N. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701034 · Cited by 95
Fukuzawa, J., Haneda, T., & Kikuchi, K. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006980517557 · Cited by 89
Plasma endothelin-1 in acute myocardial infarction with heart failure
Tomoda, H. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90155-3 · Cited by 89
Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction
Matsui, S., Ishii, J., Kitagawa, F., Kuno, A., Hattori, K., Ishikawa, M., Okumura, M., Kan, S. C., Nakano, T., Naruse, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.033 · Cited by 86
Khan, S. Q., Kelly, D., Quinn, P. A., Davies, J. E., & Ng, L. L. (2006) · Heart · doi:10.1136/hrt.2006.091041 · Cited by 80
Self-citationKhan, S. Q., Dhillon, O. S., Kelly, D., Squire, I. B., Struck, J., Quinn, P. A., Morgenthaler, N. G., Bergmann, A., Davies, J. E., & Ng, L. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.041 · Cited by 78
Self-citationImproving the Diagnosis of Acute Heart Failure Using a Validated Prediction Model
Steinhart, B. D., Thorpe, K. E., Bayoumi, A. M., Moe, G. W. P. L., Januzzi, J. L., & Mazer, C. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.065 · Cited by 75
Production and Secretion of Adrenomedullin From Glial Cell Tumors and its Effects on cAMP Production
Takahashi, K., Satoh, F., Hara, E., Sone, M., Murakami, O., Kayama, T., Yoshimoto, T., & Shibahara, S. (1997) · Peptides · doi:10.1016/s0196-9781(97)00186-1 · Cited by 71
Using C-reactive protein to assess cardiovascular disease risk.
Shishehbor, M. H., Bhatt, D. L., & Topol, E. J. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.7.634 · Cited by 70
Lorgis, L., Zeller, M., Dentan, G., Sicard, P., Buffet, P., L’Huillier, I., Beer, J., Vincent-Martin, M., Makki, H., Gambert, P., et al. (2009) · BMJ · doi:10.1136/bmj.b1605 · Cited by 61
Effects of repeated injection of local anesthetic on sciatic nerve blocks response
Chen, W., Huajping, L., Wilder, R. T., & Berde, C. B. (2004) · Current Medical Science · doi:10.1007/bf02831119 · Cited by 14
(1980) · PubMed
Cited by
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
Kang, D.-W., Park, J. G., Ilhan, Z. E., Wallstrom, G., LaBaer, J., Adams, J. B., & Krajmalnik-Brown, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068322 · Cited by 976
“, urine biomarkers for drug-induced kidney injury [39] and blood-based markers for myocardial infarction [40].”
BackgroundSimanek, A. M., Dowd, J. B., Pawelec, G., Melzer, D., Dutta, A., & Aiello, A. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016103 · Cited by 396
Metadata
- Authors
- Chan, D., & Ng, L. L.
- Venue
- BMC Medicine
- Published
- 2010-06-07
- Volume
- 8
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W1998880969
- Cited by
- 296
- References
- 94
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.